タンパク質の構成多様性の構造に基づく薬効性予測への影響

Ayse A Bekar-Cesaretli¹, Shray Vats², Adrian Whitty¹

¹Department of Chemistry, Boston University, Boston, Massachusetts 02215, United States.

Journal of chemical information and modeling

|August 22, 2025

まとめ

タンパク質の薬効性予測には希少な形状だけでなく複数の構造のコンセンサスが必要ですホットスポットの強さは鍵ですが薬剤標的の信頼性の高い評価には集合体の均一性が不可欠です

科学分野:

コンピュータ化学
構造生物学
薬物の発見

背景:

タンパク質の薬効性を予測することは薬の発見に不可欠です
タンパク質の標的はしばしば形状の多様性を表している.
この多様性が薬効性予測にどのように影響するかを理解することは不可欠です.

研究の目的:

タンパク質の薬効性予測に対する構造多様性の影響を調査する.
構造アンサンブルが単一の構造よりもより正確な薬効性に関する洞察を提供できるかどうかを判断する.

主な方法:

33のタンパク質の37の結合部位のホットスポット分析
探査ドッキングに高速フーリエ変換 (FFT) アルゴリズムを使用した.
プロテインデータバンク (PDB) のタンパク質構造集合の結合部位をマッピングした.

主要な成果:

タンパク質の薬効性を予測するには,約70%の構造で強いホットスポットについて合意が必要です.
構造物の約50%は3つの適応基準 (強度,接続性,コンパクト性) をすべて満たす必要があります.
希少な薬効性構造は不十分であり,アンサンブル均一性が重要である.

結論:

適合性の多様性は,薬効性予測の正確性に大きく影響する.
信頼性の高い薬効性評価を行うには,構造的な集合体の間でコンセンサスが必要である.
配列の不均一性は,潜在的にリガンド結合または固有の柔軟性のために,さらなる分析の必要性をシグナルします.

さらに関連する動画

06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.0K

05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

340

関連する概念動画

01:49

Conserved Binding Sites

4.3K

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...

4.3K

01:24

Protein Organization

7.0K

Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence....

7.0K

01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

253

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...

253

02:26

Conservation of Protein Domains Over Different Proteins

11.3K

Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...

11.3K

02:18

Intrinsically Disordered Proteins

18.1K

Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...

Protein Folding